BAKER BROS. ADVISORS LP → BeiGene, Ltd. BEIGF

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 3.11

81,119 shares short · +12.9% vs prior

Other 13D/G Filings on BeiGene, Ltd.

Filed	Form	Filer	Stake	Shares
2025-03-03	SCHEDULE	HHLR ADVISORS, LTD.	6.70%	92,805,741	view →

Other Filings by BAKER BROS. ADVISORS LP

Filed	Form	Issuer	Stake	Shares
2018-07-02	SC	Erytech Pharma S.A.	—	—	view →
2018-05-03	SC	INCYTE CORP INCY	—	—	view →
2018-05-02	SC	SEATTLE GENETICS INC /WA	—	—	view →
2018-03-23	SC	DBV Technologies S.A. DBVTF	—	—	view →
2018-03-12	SC	GENOMIC HEALTH INC	—	—	view →
2018-03-06	SC	IDERA PHARMACEUTICALS, INC.	—	—	view →
2018-02-05	SC	SEATTLE GENETICS INC /WA	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →